Literature DB >> 18975292

Graft histology characteristics in long-term survivors of pediatric liver transplantation.

Udeme D Ekong1, Hector Melin-Aldana, Roopa Seshadri, Joan Lokar, Dave Harris, Peter F Whitington, Estella M Alonso.   

Abstract

The factors that influence the long-term histological outcome of transplanted liver allografts in children are not yet fully understood, and the role of surveillance biopsies in patients with normal graft function remains controversial. The aims of this study were to describe the long-term graft histology of pediatric liver transplant recipients surviving at least 3 years and to analyze factors correlating with long-term histological outcome. Histological slides of 63 long-term liver transplant recipients were assessed for inflammation and fibrosis. The histological findings were correlated with clinical, biochemical, serological, and radiological findings. A significant proportion of biopsies from these patients showed some type of histological abnormalities, with fibrosis being observed in 61 (97%) patients. Duration of transplantation of >6 years and > or =grade 2 inflammation were significantly associated with advanced fibrosis. We could not identify any correlation between > or =stage 3 fibrosis and donor age, cold and warm ischemia time, history of de novo autoimmune hepatitis, hepatic artery thrombosis, chronic rejection, or alanine aminotransferase, aspartate aminotransferase, and gamma-glutamyl transferase values. In conclusion, liver fibrosis appears to be a common finding in long-term pediatric liver transplant survivors. The cause of this fibrosis is uncertain, and normal alanine aminotransferase, aspartate aminotransferase, and gamma-glutamyl transferase levels do not exclude the presence of significant fibrosis.

Entities:  

Mesh:

Year:  2008        PMID: 18975292     DOI: 10.1002/lt.21549

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  18 in total

Review 1.  What determines ageing of the transplanted liver?

Authors:  Russell Hodgson; Chris Christophi
Journal:  HPB (Oxford)       Date:  2014-09-28       Impact factor: 3.647

2.  Protocol liver biopsy is the only examination that can detect mid-term graft fibrosis after pediatric liver transplantation.

Authors:  Yukihiro Sanada; Koshi Matsumoto; Taizen Urahashi; Yoshiyuki Ihara; Taiichi Wakiya; Noriki Okada; Naoya Yamada; Yuta Hirata; Koichi Mizuta
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

3.  Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury.

Authors:  Yuan Liu; Tianfei Lu; Cheng Zhang; Jin Xu; Zhengze Xue; Ronald W Busuttil; Ning Xu; Qiang Xia; Jerzy W Kupiec-Weglinski; Haofeng Ji
Journal:  J Hepatol       Date:  2019-06-13       Impact factor: 25.083

4.  Five-year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R.

Authors:  Sandy Feng; Anthony J Demetris; Katharine M Spain; Sai Kanaparthi; Bryna E Burrell; Udeme D Ekong; Estella M Alonso; Philip Rosenthal; Laurence A Turka; David Ikle; Nadia K Tchao
Journal:  Hepatology       Date:  2016-07-27       Impact factor: 17.425

Review 5.  Current developments in pediatric liver transplantation.

Authors:  Christina Hackl; Hans J Schlitt; Michael Melter; Birgit Knoppke; Martin Loss
Journal:  World J Hepatol       Date:  2015-06-18

6.  Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver Transplants.

Authors:  Sandy Feng; John C Bucuvalas; Anthony J Demetris; Bryna E Burrell; Katherine M Spain; Sai Kanaparthi; John C Magee; David Ikle; Andrew Lesniak; Juan J Lozano; Estella M Alonso; Robert A Bray; Nancy E Bridges; Edward Doo; Howard M Gebel; Nitika A Gupta; Ryan W Himes; Annette M Jackson; Steven J Lobritto; George V Mazariegos; Vicky L Ng; Elizabeth B Rand; Averell H Sherker; Shikha Sundaram; Yumirle P Turmelle; Alberto Sanchez-Fueyo
Journal:  Gastroenterology       Date:  2018-08-23       Impact factor: 22.682

Review 7.  Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation.

Authors:  Antonio Cuadrado; David San Segundo; Marcos López-Hoyos; Javier Crespo; Emilio Fábrega
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

Review 8.  The SPLIT research agenda 2013.

Authors:  Estella M Alonso; Vicky L Ng; Ravinder Anand; Christopher D Anderson; Udeme D Ekong; Emily M Fredericks; Katryn N Furuya; Nitika A Gupta; Stacee M Lerret; Shikha Sundaram; Greg Tiao
Journal:  Pediatr Transplant       Date:  2013-05-30

9.  Production of Proinflammatory Cytokines by Monocytes in Liver-Transplanted Recipients with De Novo Autoimmune Hepatitis Is Enhanced and Induces TH1-like Regulatory T Cells.

Authors:  Adam S Arterbery; Awo Osafo-Addo; Yaron Avitzur; Maria Ciarleglio; Yanhong Deng; Steven J Lobritto; Mercedes Martinez; David A Hafler; Markus Kleinewietfeld; Udeme D Ekong
Journal:  J Immunol       Date:  2016-04-18       Impact factor: 5.422

Review 10.  Long term outcomes after pediatric liver transplantation.

Authors:  Nada A Yazigi
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2013-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.